Activation of glioma cells generates immune tolerant NKT cells

Journal of Biological Chemistry

Volumn 289, Issue 50, 2014, Pages 34595-34600

  Tang, Bo ^a   Wu, Wei ^b   Wei, Xiaowei ^c   Li, Yang ^a   Ren, Gang ^c   Fan, Wenhai ^c  

^a GUILIN MEDICAL UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c DALIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; T-CELLS;

CELL ACTIVITY; GLIOMA CELL LINES; GLIOMA CELLS; GLIOMA TISSUES; NATURAL KILLER T CELL; REAL TIME RT-PCR; THERAPEUTIC OUTCOMES; TUMOR DEVELOPMENT;

TUMORS;

FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MICRORNA; MICRORNA 92A; PERFORIN; UNCLASSIFIED DRUG; MIRN92 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; NATURAL KILLER T CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; IMMUNOLOGY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-6; MICRORNAS; NATURAL KILLER T-CELLS;

EID: 84918517100     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.614503     Document Type: Article

References (16)

1. Janz, C., and Buhl, R. (2014) Astroblastoma: Report of two cases with unexpected clinical behavior and review of the literature. Clin. Neurol. Neurosurg. 125, 114-124
2. + T Cells. PLoS ONE 9, e105350
3. Berzins, S. P., and Ritchie, D. S. (2014) Natural killer T cells: drivers or passengers in preventing human disease? Nat. Rev. Immunol. 14, 640-646
4. Hegde, S., Fox, L., Wang, X., and Gumperz, J. E. (2010) Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells. Immunology 130, 471-483
5. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., and Baltimore, D. (2010) Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10, 111-122
6. + Regulatory T Cells. PLoS ONE 9, e88997
7. Hanin, G., Shenhar-Tsarfaty, S., Yayon, N., Hoe, Y. Y., Bennett, E. R., Sklan, E. H., Rao, D., Rankinen, T., Bouchard, C., Geifman-Shochat, S., Shifman, S., Greenberg, D. S., and Soreq, H. (2014) Competing targets of microRNA-608 affect anxiety and hypertension. Hum. Mol. Genet. 23, 4569-4580
8. Xie, N., Cui, H., Banerjee, S., Tan, Z., Salomao, R., Fu, M., Abraham, E., Thannickal, V. J., Liu, G. (2014) miR-27a Regulates Inflammatory Response of Macrophages by Targeting IL-10. J. Immunol. 193, 327-334
9. Li, M., Guan, X., Sun, Y., Mi, J., Shu, X., Liu, F., and Li, C. (2014) miR-92a family and their target genes in tumorigenesis and metastasis. Exp. Cell Res. 323, 1-6
10. Quezada, S. A., Peggs, K. S., Simpson, T. R., and Allison, J. P. (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 241, 104-118
11. Biragyn, A., Lee-Chang, C., and Bodogai, M. (2014) Generation and identification of tumor-evoked regulatory B cells. Methods Mol. Biol. 1190, 89
12. Pan, Y. F., Tan, Y. X., Wang, M., Zhang, J., Zhang, B., Yang, C., Ding, Z. W., Dong, L. W., and Wang, H. Y. (2013) Signal regulatory protein α is associated with tumor-polarized macrophages phenotype switch and plays a pivotal role in tumor progression. Hepatology 58, 680-691
13. Sag, D., Krause, P., Hedrick, C. C., Kronenberg, M., and Wingender, G. (2014) IL-10GÇôproducing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124, 3725-3740
14. Yin, Z., Lu, G., Xiao, Z., Liu, T., He, X., Wang, Q., Lin, C., and Zhang, S. (2014) Antitumor efficacy of argon-helium cryoablation-generated dendritic cell vaccine in glioma. Neuroreport. 25(4):199-204
15. Li, R., Li, X., Ning, S., Ye, J., Han, L., Kang, C., Li X. (2014) Identification of a Core miRNA-Pathway Regulatory Network in Glioma by Therapeutically Targeting miR-181d, miR-21, miR-23b, beta Catenin, CBP, and STAT3. PLoS ONE 9, e101903
16. Wang, L., Shi, Z. M., Jiang, C. F., Liu, X., Chen, Q. D., Qian, X., Li, D. M., Ge, X., Wang, X. F., Liu, L. Z., You, Y. P., Liu, N., and Jiang, B. H. (2014) MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Oncotarget 5, 5416-5427